Literature DB >> 22406919

Correlation of non-mass-like abnormal MR signal intensity with pathological findings surrounding pediatric osteosarcoma and Ewing's sarcoma.

Karim Z Masrouha1, Khaled M Musallam, Alexis Bou Samra, Ayman Tawil, Rachid Haidar, Zaher Chakhachiro, Said Saghieh, Abeer Abdallah, Raya Saab, Samar Muwakkit, Miguel R Abboud, Nabil J Khoury.   

Abstract

OBJECTIVE: The aim of this work was to determine the role of MRI in interpreting abnormal signals within bones and soft tissues adjacent to tumor bulk of osteosarcoma and Ewing's sarcoma in a pediatric population by correlating MR findings with histopathology.
MATERIALS AND METHODS: Thirty patients met the inclusion criteria, which included (1) osteosarcoma or Ewing's sarcoma, (2) MR studies no more than 2 months prior to surgery, (3) presence of abnormal MR signal surrounding the tumor bulk, (4) pathological material from resected tumor. The patients received standard neoadjuvant chemotherapy. Using grid maps on gross pathology specimens, the abnormal MR areas around the tumor were matched with the corresponding grid sections. Histopathology slides of these sections were then analyzed to determine the nature of the regions of interest. The MR/pathological correlation was evaluated using Mann-Whitney U test and Fisher's exact test.
RESULTS: Twenty-seven patients had osteosarcoma and three patients had Ewing's sarcoma. Of the studied areas, 17.4% were positive for tumor (viable or necrotic). There was no statistically significant correlation between areas positive for tumor and age, gender, signal extent and intensity on MRI, or tissue type. There was, however, a statistically significant correlation between presence of tumor and the appearance of abnormal soft tissue signals. A feathery appearance correlated with tumor-negative areas whereas a bulky appearance correlated with tumor-positive regions.
CONCLUSIONS: MR imaging is helpful in identifying the nature of abnormal signal areas surrounding bone sarcomas that are more likely to be tumor-free, particularly when the signal in the soft tissues surrounding the tumor is feathery and edema-like in appearance.

Entities:  

Mesh:

Year:  2012        PMID: 22406919     DOI: 10.1007/s00256-012-1383-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  20 in total

1.  Musculoskeletal neoplasms: static and dynamic Gd-DTPA--enhanced MR imaging.

Authors:  R Erlemann; M F Reiser; P E Peters; P Vasallo; B Nommensen; C R Kusnierz-Glaz; J Ritter; A Roessner
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

2.  Comparison of STIR and spin-echo MR imaging at 1.5 T in 45 suspected extremity tumors: lesion conspicuity and extent.

Authors:  W P Shuman; R M Patten; R L Baron; R M Liddell; E U Conrad; M L Richardson
Journal:  Radiology       Date:  1991-04       Impact factor: 11.105

Review 3.  Primary bone osteosarcoma in the pediatric age: state of the art.

Authors:  Alessandra Longhi; Costantino Errani; Massimiliano De Paolis; Mario Mercuri; Gaetano Bacci
Journal:  Cancer Treat Rev       Date:  2006-07-24       Impact factor: 12.111

4.  Magnetic resonance imaging in planning limb-salvage surgery for primary malignant tumors of bone.

Authors:  M Sundaram; M H McGuire; D R Herbold; M K Wolverson; E Heiberg
Journal:  J Bone Joint Surg Am       Date:  1986-07       Impact factor: 5.284

Review 5.  Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

Authors:  Hervé Brisse; Liliane Ollivier; Véronique Edeline; Hélène Pacquement; Jean Michon; Christophe Glorion; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2004-04-22

Review 6.  Bone marrow oedema associated with benign and malignant bone tumours.

Authors:  S L J James; D M Panicek; A M Davies
Journal:  Eur J Radiol       Date:  2008-03-20       Impact factor: 3.528

7.  Preoperative staging of osteosarcoma: efficacy of MR imaging in detecting joint involvement.

Authors:  W Schima; G Amann; R Stiglbauer; R Windhager; J Kramer; M Nicolakis; M T Farres; H Imhof
Journal:  AJR Am J Roentgenol       Date:  1994-11       Impact factor: 3.959

Review 8.  Diagnosis and management of bone malignancy in adolescence.

Authors:  Jonathan S C Caudill; Carola A S Arndt
Journal:  Adolesc Med State Art Rev       Date:  2007-05

9.  Extremity osteosarcoma in childhood: prognostic value of radiologic imaging.

Authors:  J A Lawrence; P S Babyn; H S Chan; P S Thorner; G E Pron; I J Krajbich
Journal:  Radiology       Date:  1993-10       Impact factor: 11.105

10.  Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement rates.

Authors:  P Lang; G Honda; T Roberts; M Vahlensieck; J O Johnston; W Rosenau; A Mathur; C Peterfy; C A Gooding; H K Genant
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

View more
  5 in total

1.  How PET/MR Can Add Value For Children With Cancer.

Authors:  Heike Daldrup-Link
Journal:  Curr Radiol Rep       Date:  2017-02-21

2.  Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome.

Authors:  Christoph J Laux; Gundula Berzaczy; Michael Weber; Susanna Lang; Martin Dominkus; Reinhard Windhager; Iris-Melanie Nöbauer-Huhmann; Philipp T Funovics
Journal:  Int Orthop       Date:  2014-11-30       Impact factor: 3.075

3.  Childhood Facial Osteo Sarcoma: a Case Report.

Authors:  Hamid Farhangi; Mahdi Farzadnia; Ali Alamdaran
Journal:  Arch Bone Jt Surg       Date:  2015-04

Review 4.  Multiparametric MRI evaluation of bone sarcomas in children.

Authors:  Emilio J Inarejos Clemente; Oscar M Navarro; Maria Navallas; Enrique Ladera; Ferran Torner; Mariona Sunol; Moira Garraus; Jordi Català March; Ignasi Barber
Journal:  Insights Imaging       Date:  2022-03-01

5.  Preliminary clinical research on epiphyseal distraction in osteosarcoma in children.

Authors:  Songtao Gao; Yan Zheng; Qiqing Cai; Weitao Yao; Jiaqiang Wang
Journal:  World J Surg Oncol       Date:  2014-08-07       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.